DXR
Daxor Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$10.27
−2.66%Margins
Gross margin
54.6%
EBITDA margin
1102.2%
EBIT margin
940.4%
Net margin
924.1%
FCF margin
-327.0%
15.5%
Return on equity
15.5%
Return on assets
15.8%
Return on invested capital
0.02x
Asset turnover
-$2.8M
Cash from operations
$0.99
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026